The deeper threat to the biopharmaceutical industry may come not from macro-level disruption, but from structural pressures ...
How AI and other digital tools are progressing across the bio/pharmaceutical industry is on top of mind. Key perspectives on ...
Merck KGaA has agreed to acquire Silence Therapeutics, a Cambridge, UK-based clinical-stage bio/pharmaceutical company developing short interfering RNA (siRNA) medicines, for $1.3 billion, ...
Sanofi has broken ground on a new insulin manufacturing facility in Frankfurt, Germany. The new facility will be built on a 36,000-square-meter footprint at the Sanofi BioCampus in Frankfurt.
The Board of Directors of CSL, a Melbourne, Australia-based bio/pharmaceutical company, has appointed Deborah Waterhouse, currently Chief Executive Officer (CEO) of ViiV Healthcare, a joint venture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results